Dr. Alline C. Campos is a neuroscientist and pharmacologist whose research bridges neuropsychopharmacology, neurodevelopment, and neuroplasticity. She earned her B.Pharm, M.Sc., and Ph.D. in Pharmacology/Psychopharmacology in Brazil, followed by postdoctoral training at Max Planck Institute. A 2015 L’Oréal-UNESCO For Women in Science fellow, she currently leads the Pharmacology of Neuroplasticity Lab and the preclinical arm of Cannabinoid Research Center at the Ribeirão Preto Medical School- University of São Paulo. Her research focuses on identifying neuroplasticity mechanisms underlying psychiatric and neurodevelopmental disorders and converting them into druggable targets. Dr. Campos has contributed significantly to understanding how cannabinoids—particularly cannabidiol—modulate neuroplastic events, oxidative stress, and neuroinflammation.